3 March 2015
KNOW MORE EVONIK CEO, KLAUS ENGEL
DETAILS
Key figures for 2014
- Net income was €568 million
(2013: €2,054 million, boosted by the proceeds
from the sale of the real estate business).
Adjusted net income
was €740 million (2013: €806 million). - Adjusted earnings per share were €1.59
(2013: €1.73) - Adjusted EBITDA was €1.9 billion
(2013: €2.0 billion) and therefore within the forecast range. - The adjusted EBITDA margin remained solid at 14.5 percent
(2013: 15.7 percent). - The Evonik Group grew sales 2 percent to €12.9 billion
(2013: €12.7 billion). - High volumes (+3 percent) and
slightly lower selling prices (-1 percent),
giving organic growth of 2 percent.
Looking ahead to fiscal 2015,
Engel said that on the basis that had been created
Evonik expected to report a slight increase in sales and
the operating result in 2015.
Given the strong start to the year
he is optimistic that Evonik will achieve its targets.
WWW.CHEMWINFO.COM BY KHUN PHICHAI
